Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Human Life
100%
Chemokines
100%
Plasma Cytokines
100%
First Week
100%
First Week of Life
55%
Immune System
11%
Gestational Age
11%
Interleukin-10
11%
Prematurity
11%
Vulnerability
11%
Healthy children
11%
Multiplex Assay
11%
Host Defense
11%
Immune Signaling
11%
Interleukin-6
11%
Dynamic Change
11%
Interleukin-4 (IL-4)
11%
At Birth
11%
West Africa
11%
Limited Information
11%
CCL5
11%
Gambia
11%
Increased Vulnerability
11%
Severe Infection
11%
Medical Research Council
11%
Small Sample Size
11%
Susceptibility to Infection
11%
Unsupervised Clustering
11%
Longitudinal Cohort
11%
Th1 Cytokines
11%
Defense Pathways
11%
Follow-up Time
11%
Cross-sectional Study Design
11%
CXCL8
11%
Anti-inflammatory Cytokines
11%
Peripheral Plasma
11%
Ontogenetic Pattern
11%
CXCL10
11%
Full-term Infants
11%
Changing Demand
11%
Host State
11%
Bead-based
11%
Rapidly Evolving
11%
Neonatal Immune System
11%
Transition to Extrauterine Life
11%
Immune Ontogeny
11%
Cytokine multiplex
11%
Immunology and Microbiology
Blood Plasma
100%
Ontogeny
100%
Cytokine
100%
Chemokine
100%
Infection
30%
Immune System
20%
Inflammatory Cytokine
10%
Interleukin 10
10%
Host Resistance
10%
Upregulation
10%
Interleukin 6
10%
Sample Size
10%
CXCL10
10%
CCL5
10%
Interleukin 4
10%
Susceptibility
10%
Biochemistry, Genetics and Molecular Biology
Ontogeny
100%
Cytokine
100%
Chemokine
100%
Blood Plasma
100%
Cross Sectional Study
10%
Inflammatory Cytokine
10%
Host Resistance
10%
Upregulation
10%
Sample Size
10%
Antigen Antibody Complex
10%
CCL5
10%
CXCL10
10%
Interleukin 10
10%
Interleukin 6
10%
Interleukin 4
10%
Anti-Inflammatory
10%
Neuroscience
Chemokine
100%
Ontogeny
100%
Blood Plasma
100%
Cytokine
100%
Anti-Inflammatory
9%
CCL5
9%
Interleukin 4
9%
Interleukin 6
9%
Interleukin 10
9%
CXCL10
9%
Antigen Antibody Complex
9%